Mkts

Arrowhead Pharmaceuticals, Inc.

NASDAQ: ARWR
$49.24-8.92 (-15.34%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
46.4553.63
52-week range
37.0695.49
Today
Open52.49
Previous close49.24
Volume1.77M
Valuation
Market cap6.73B
P/E ratio—
EPS (TTM)-2.24
Income & risk
Dividend / yield—
Beta1.39
Avg volume1.85M
Discussion

ARWR News

Stories mentioning ARWR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue73,737264,033256,47227,767542,7092,5000.000.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development173,253177,203133,102137,002
Sales General & Admin41,74428,405
Total Operating Expenses214,997223,224212,366193,317161,507163,912162,203176,141
Operating Income (Loss)(141,260)40,80944,106(165,550)381,202(161,412)(162,203)(176,141)
Interest Income
Interest Expense
Other Expense(1,609)277.004,656(176.00)438.00341.00(3,118)760.00
Pretax Income(137,565)28,27136,121(179,089)369,616(175,115)(172,798)(173,977)
Tax Provision7.0029.0020,000(437.00)1,753103.00546.000.00
Net Income (Loss)(132,732)30,811(23,750)(175,241)370,445(173,085)(170,536)(170,793)
Earnings Per Share (Basic)(0.93)0.22(0.18)(1.26)2.78(1.39)(1.42)(1.38)
Earnings Per Share (Diluted)(0.93)0.22(0.18)(1.26)2.75(1.39)(1.42)(1.38)
Weighted Average Shares Outstanding (Basic)142,417137,039133,758139,039133,363124,848119,784124,199
Weighted Average Shares Outstanding (Diluted)142,417140,706133,758139,039134,484124,848119,784124,199

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ARWR

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is a stock listed on the Nasdaq Stock Market under the ticker symbol ARWR. It last traded at $49.24 (Nov 9, 2026, 4:00 PM ET), down 15.3% on the day. That gives Arrowhead Pharmaceuticals a market capitalisation of $6.7B.

Over the past 52 weeks ARWR has traded between $37.06 and $95.49.

Revenue for the quarter ended Mar 31, 2026 was $73.7M; a net loss of $132.7M. Revenue was down 86.4% from $542.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$73.7M-$132.7M-180.0%
Dec 31, 2025$264.0M$30.8M11.7%
Sep 30, 2025$256.5M-$23.8M-9.3%
Jun 30, 2025$27.8M-$175.2M-631.1%

From Arrowhead Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…